Pharma Marketing Network

Medical Marketing & Media (MM&M), one of the more interesting industry magazines, just printed a piece by my friend and colleague, Harry Sweeney, called...

Featured Conference 4th Annual Pharmaceutical Marketing & Sales Summit April 4 - 5, 2006 * Hyatt...

In one fell swoop the new erectile dysfuntion (ED) 'disease awareness' ads have expanded the market for ED while at the same time managed to come up smelling like roses by complying with PhRMA's Guiding Principles for DTC Advertising. 'Disease mongering' (aka, 'indication bloat') -- or, if you prefer, 'disease awareness'-- efforts are a rising tide that will float all ED drug ships.

In one fell swoop the new erectile dysfuntion (ED) 'disease awareness' ads have expanded the market for ED while at the same time managed to come up smelling like roses by complying with PhRMA's Guiding Principles for DTC Advertising. 'Disease mongering' (aka, 'indication bloat') -- or, if you prefer, 'disease awareness'-- efforts are a rising tide that will float all ED drug ships.

The author argues that the pharmaceutical industry should make a more aggressive push towards the inclusion of their clinically relevant content at the point-of-prescription in on-line managed care formulary lookups and ePrescribing transactions. Only then will the industry begin to change what is looking like a threatening future to one which offers the industry a more level playing field.

Reprints from medical journals are an integral part of the pharmaceutical industry's physician sales and marketing effort. This article describes the reprint management services provide by Reprints Desk, a new company formed by content professionals with over 50 years of experience serving customers and publishers in healthcare.

Pharma Marketing Network hosted an online survey asking respondents' opinions regarding the the Coalition for Healthcare Communication's petition to the FDA.

This article presents a lightly edited transcript of a Pharma Marketing Roundtable discussion of the March 31, 2006 Coalition for Healthcare Communication's Citizens Petition to the FDA seeking new prescription drug advertising rules to simply the communication of risk information in DTC ads.

The Coalition for Healthcare Communication (CHC) -- comprised of major advertising, marketing and PR organizations, including the American Association of Advertising Agencies, the...

According to an article in the March 27, 2006 edition of the Wall Street Journal ("Bureaucracy Buster? Glaxo Lets Scientists Choose Its New Drugs"),...